September 21, 2011

Sanofi Pasteur Acquires Exclusive, Worldwide License for Acne Vaccine and Treatment

- The pre-clinical vaccine was developed by researchers at the University of California, San Diego -

 

Sanofi Pasteur Acquires Exclusive, Worldwide License for Acne Vaccine and Treatment
- The pre-clinical vaccine was developed by researchers at the University of California, San Diego -

Lyon, France – September 21, 2011 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today a research and development collaboration with the University of California, San Diego (UC San Diego) on an immunological approach to acne prevention and treatment targeting the specific neutralization of Propionibacterium acnes factors in inflammation.